FDA Voluntary Recall of Ranitidine (Zantac)

Recently, ranitidine (Zantac), and potentially other similar drugs in the same class, have been removed from shelves worldwide as a precautionary measure citing a contamination/safety concern.  If you or a family member take this type of heartburn medication, we encourage you to reach out to your DHP provider or primary care physician to see if a switch to another medication is recommended in your situation.  Pepcid (famotidine) is sometimes recommended as an equivalent over-the-counter optionPatient safety is our first priority. We will provide updates, if needed, through our patient portal.  

https://www.fda.gov/news-events/press-announcements/statement-alerting-patients-and-health-care-professionals-ndma-found-samples-ranitidine

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/apotex-corp-issues-voluntary-nationwide-recall-ranitidine-tablets-75mg-and-150mg-all-pack-sizes-and

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sandoz-inc-issues-voluntary-recall-ranitidine-hydrochloride-capsules-150mg-and-300mg-due-elevated